News Website

Correction: Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via SPOP/ERα axis - Cell Communication and Signaling

Correction: Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via SPOP/ERα axis Cell Communication and Signaling

Published: Oct. 24, 2025, 12:50 p.m.

Read Full Article

Every Woman: Breast Cancer Awareness - FRCN HQ

Every Woman: Breast Cancer Awareness FRCN HQ

Published: Oct. 23, 2025, 10:43 p.m.

Read Full Article

WES-Aneuploidy Scores May Be Prognostic for Immunotherapy in dMMR Endometrial Cancer - OncLive

WES-Aneuploidy Scores May Be Prognostic for Immunotherapy in dMMR Endometrial Cancer OncLive

Published: Oct. 23, 2025, 6:03 p.m.

Read Full Article

Rising Cancer Rates Among Young Adults Spur Global Alarm - Evrim Ağacı

Rising Cancer Rates Among Young Adults Spur Global Alarm Evrim Ağacı

Published: Oct. 23, 2025, 2:54 a.m.

Read Full Article

Endometrial Cancer and Body Image: How to Cope and Rebuild Confidence - Everyday Health

Endometrial Cancer and Body Image: How to Cope and Rebuild Confidence Everyday Health

Published: Oct. 22, 2025, 7:12 p.m.

Read Full Article

Frontline Strategy: Why You Must Use IO Upfront in Endometrial Cancer - Targeted Oncology

Frontline Strategy: Why You Must Use IO Upfront in Endometrial Cancer Targeted Oncology

Published: Oct. 22, 2025, 6:21 p.m.

Read Full Article

Endometrial Cancer: Dostarlimab/Chemo Improves OS in Frontline RUBY Trial - Targeted Oncology

Endometrial Cancer: Dostarlimab/Chemo Improves OS in Frontline RUBY Trial Targeted Oncology

Published: Oct. 22, 2025, 5:11 p.m.

Read Full Article

KEYTRUDA + LENVIMA shows durable 5-year survival benefit in advanced endometrial cancer - Indian Pharma Post

KEYTRUDA + LENVIMA shows durable 5-year survival benefit in advanced endometrial cancer Indian Pharma Post

Published: Oct. 22, 2025, 5:03 p.m.

Read Full Article

ASCO Reading Room | Here's How the Treatment Landscape for Gynecologic Cancers Is About to Change - MedPage Today

ASCO Reading Room | Here's How the Treatment Landscape for Gynecologic Cancers Is About to Change MedPage Today

Published: Oct. 22, 2025, 2:54 p.m.

Read Full Article

French medical technology company EDAP secures €36 million credit facility from EIB to advance prostate cancer and endometriosis non-invasive treatment - The European Sting

French medical technology company EDAP secures €36 million credit facility from EIB to advance prostate cancer and endometriosis non-invasive treatment The European Sting

Published: Oct. 22, 2025, 2 p.m.

Read Full Article

Latest Articles

Correction: Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via SPOP/ERα axis - Cell Communication and Signaling

Every Woman: Breast Cancer Awareness - FRCN HQ

WES-Aneuploidy Scores May Be Prognostic for Immunotherapy in dMMR Endometrial Cancer - OncLive

Rising Cancer Rates Among Young Adults Spur Global Alarm - Evrim Ağacı

Endometrial Cancer and Body Image: How to Cope and Rebuild Confidence - Everyday Health

Frontline Strategy: Why You Must Use IO Upfront in Endometrial Cancer - Targeted Oncology

Endometrial Cancer: Dostarlimab/Chemo Improves OS in Frontline RUBY Trial - Targeted Oncology

KEYTRUDA + LENVIMA shows durable 5-year survival benefit in advanced endometrial cancer - Indian Pharma Post

ASCO Reading Room | Here's How the Treatment Landscape for Gynecologic Cancers Is About to Change - MedPage Today

French medical technology company EDAP secures €36 million credit facility from EIB to advance prostate cancer and endometriosis non-invasive treatment - The European Sting

Subscribe to Our Newsletter